Log in with your email address username.

×

Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Department of Error] Department of Error

Williams HC, Wojnarowska F, Kirtschig G, et al, on behalf of the UK Dermatology Clinical Trials Network BLISTER Study Group. Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial. Lancet 2017; 389: 1630–38—In this Article (published online first on March 6, 2017), in the UK Dermatology Clinical Trials Network BLISTER Study Group list of names, C DeGiovanni was incorrectly listed as C Barnard. This correction has been made to the online version as of Oct 26, 2017.

email